HOME >> BIOLOGY >> NEWS
Gulf between rich, poor will grow if high-profile nanotechnology opponents prevail: ethics experts

The chasm between have and have-not countries will grow even wider if nanotechnology research is upended by the unbalanced positions of high-profile opponents like Prince Charles, warns a new analysis from a leading global medical ethics think-tank.

Nanotechnology is the building of working devices, systems and materials molecule by molecule by manipulating matter measured in billionths of a meter. The research seeks to exploit the unique and powerful electrical, physical and chemical properties found at an infinitesimally small scale.

While legitimate risks and issues have been flagged, they can and should be addressed without a crippling moratorium being called for on budding research that promises vast improvement in the lives of five billion people in developing countries, according to medical ethics experts at the University of Toronto Joint Centre for Bioethics.

In an article to be published by the Institute of Physics' journal "Nanotechnology," and released Wednesday, Jan. 28 online at Nanotechweb.org, the JCB authors say the potential health, environmental and economic benefits for developing countries of nanotechnology (NT) include:

  • Improved detection of cancer and HIV/AIDS by tagging biological molecules with nanometer-sized markers, avoiding in the process many drawbacks associated with organic dyes conventionally used to mark cells;

  • Improved detection of tuberculosis with quantum dot optical biosensors. Development plans for a nanotech-based diagnostic kit to reduce the cost, time and the amount of blood required for TB tests was recently announced in India;

  • Inexpensive miniaturized medical diagnostic devices easily used in remote regions;

  • More effective delivery of drugs and vaccines packaged in nano-particles, allowing more precise targeting to areas of the body where medications are needed, thereby producing stronger respon
    '"/>


Contact: Terry Collins
collins1@sympatico.ca
416-538-8712
International Institute for Sustainable Development
27-Jan-2004


Page: 1 2 3

Related biology news :

1. Landmark agreement between Samoa and UC Berkeley could help search for AIDS cure
2. New research suggests link between maternal diet and childhood leukemia risk
3. Fossils reveal direct link between global warming and genetic diversity in wildlife
4. Battle between bubbles might have started evolution
5. UCSD researchers are first to demonstrate molecular link between inflammation and cancer
6. New survey reveals insights into unique relationship between mothers and pediatricians
7. Study explains spatial orientation differences between sexes
8. New technique helps scientists reveal interactions between genes and drugs
9. Unique partnership between UH, FDA opens path for scientific exchange
10. Study supports association between HPV infection and head and neck cancer
11. OneWorld Health CEO outlines mutually beneficial collaborations between industry, nonprofits at BIO

Post Your Comments:
(Date:10/30/2014)... therapeutics present unique challenges when it comes to ... harm. New consensus guidelines for toxicity testing that ... characteristics of these novel biopharmaceuticals are presented in ... from Mary Ann Liebert, Inc. publishers . ... Nucleic Acid Therapeutics website until November 30, ...
(Date:10/30/2014)... Oct. 29, 2014  Securus Technologies, a ... technology solutions for public safety, investigation, corrections ... deployed exciting enhancements to its THREADS™ product, ... provide actionable intelligence and focused leads for ... drive technological innovation through identifying and delivering ...
(Date:10/29/2014)... Beaverton, OR) New research presented at the ... in Houston, TX showed for the first time ... in women using a readily available nutritional supplement, ... by Dr. Judith A. Smith, Pharm.D., associate professor ... Sciences at The University of Texas Health Science ...
Breaking Biology News(10 mins):New guidelines for reproductive & developmental toxicity testing of oligonucleotide drugs 2Securus Technologies Adds Advanced Features to Its Industry-Leading Investigative Analytics Product 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2
(Date:10/30/2014)... , Oct. 30, 2014  Regado Biosciences, Inc. ... will hold a conference call and live audio webcast ... to discuss its third quarter 2014 financial results. ... call by dialing (888) 347-1165 for domestic callers or ... be webcast live under the investor relations section of ...
(Date:10/30/2014)... (Oct. 29, 2014) – The severe flooding that devastated ... been less destructive if the bridges, roads and other ... new study from the University of Colorado Denver. , ... infrastructure," said Jimmy Kim, PhD, associate professor of structural ... Applied Science and lead author the study. "There is ...
(Date:10/27/2014)... October 27, 2014 The new ... Type (High & Medium), Sub-type (Primary & Secondary), ... Infrastructure & Transportation & Power Generation) - Trends ... GIS market with analysis and forecasting of the ... Data Tables with 52 Figures spread through 146 ...
(Date:10/27/2014)... TORONTO , Oct. 27, 2014 ... (OTCQB: GNBT) today announced two presentations demonstrating that ... its novel proprietary cancer immunotherapeutic AE37 vaccine correlated ... patients. The AE37 cancer vaccine is being developed ... ( www.antigenexpress.com ). The presentations are being made ...
Breaking Biology Technology:Regado Biosciences to Provide Third Quarter 2014 Financial Results 2CU Denver study says upgrading infrastructure could reduce flood damage 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 2Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 3Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 4
Cached News: